Publications Repository

Publications Repository

Search 
  •   Home
  • ICR Divisions
  • Search
  • Home
  • ICR Divisions
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show advanced filtersHide advanced filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 1030

  • Sort Options:
  • Relevance
  • Issue date (newest)
  • Issue date (oldest)
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

HER3 Is an Actionable Target in Advanced Prostate Cancer. 

Gil, V; Miranda, S; Riisnaes, R; Gurel, B; D'Ambrosio, M; et al.
It has been recognized for decades that ERBB signaling is important in prostate cancer, but targeting ERBB receptors as a therapeutic strategy for prostate cancer has been ineffective clinically. However, we show here that ...
Thumbnail

A comparison of the diagnostic value of MRI and 18 F-FDG-PET/CT in suspected spondylodiscitis. 

Smids, C; Kouijzer, IJE; Vos, FJ; Sprong, T; Hosman, AJF; et al. (2017-02)
Purpose The purpose of this study was to evaluate the diagnostic value of 18 F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT scan) and magnetic resonance imaging (MRI) in diagnosing ...
Thumbnail

Reply from Authors re: Tillmann Loch, Pat Fox Fulgham. Active Surveillance Challenges in Men with Prostate Cancer: Role of Imaging Today and Tomorrow. Eur Urol 2016;69:1034-6: Imaging in Active Surveillance for Prostate Cancer: Where Should We Focus Our Research? 

Henderson, DR; de Souza, NM; Parker, CC; van As, NJ (2016-06)
Thumbnail

Predictors of histological disease progression in untreated, localized prostate cancer. 

Venkitaraman, R; Norman, A; Woode-Amissah, R; Fisher, C; Dearnaley, D; et al. (2007-09)
Active surveillance for early prostate cancer is a policy of close monitoring with radical treatment targeted at cases with evidence of disease progression. There is no consensus on the need for or optimum timing of repeat ...
Thumbnail

Dosimetry-based treatment for Graves' disease. 

Hyer, SL; Pratt, B; Gray, M; Chittenden, S; Du, Y; et al. (2018-06)
Objective The aim of this retrospective study was to assess the long-term outcome of a personalized dosimetry approach in Graves' disease aiming to render patients euthyroid from a planned thyroid absorbed dose of ...
Thumbnail

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer. 

Sundar, R; Miranda, S; Rodrigues, DN; Chénard-Poirier, M; Dolling, D; et al. (2018-12)
Background Loss of ataxia telangiectasia mutated (ATM), a key protein regulating DNA repair signaling, has been suggested to increase sensitivity to DNA damaging agents. We conducted a study analyzing the loss of ATM protein ...
Thumbnail

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. 

Newsome, PN; Fox, R; King, AL; Barton, D; Than, N-N; et al. (2018-01)
Background Results of small-scale studies have suggested that stem-cell therapy is safe and effective in patients with liver cirrhosis, but no adequately powered randomised controlled trials have been done. We assessed the ...
Thumbnail

The Association of Intraoperative driving pressure with postoperative pulmonary complications in open versus closed abdominal surgery patients - a posthoc propensity score-weighted cohort analysis of the LAS VEGAS study. 

Mazzinari, G; Serpa Neto, A; Hemmes, SNT; Hedenstierna, G; Jaber, S; et al. (2021-03-19)
<h4>Background</h4>It is uncertain whether the association of the intraoperative driving pressure (ΔP) with postoperative pulmonary complications (PPCs) depends on the surgical approach during abdominal surgery. Our primary ...
Thumbnail

Online dose reconstruction for tracked volumetric arc therapy: Real-time implementation and offline quality assurance for prostate SBRT. 

Kamerling, CP; Fast, MF; Ziegenhein, P; Menten, MJ; Nill, S; et al. (2017-11)
Purpose Firstly, this study provides a real-time implementation of online dose reconstruction for tracked volumetric arc therapy (VMAT). Secondly, this study describes a novel offline quality assurance tool, based on ...

Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme. 

Davidson, M; Aronson, LI; Howard-Reeves, J; Bryant, H; Cutts, RJ; et al. (2019-11)
Introduction The MYC proto-oncogene is among the most commonly dysregulated genes in human cancers. We report screening data from the iMYC trial, an ongoing phase II study assessing ibrutinib monotherapy in advanced ...
  • «
  • 1
  • 2
  • 3
  • 4
  • . . .
  • 103
  • »

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis communityBy issue dateAuthorsTitlesPublication Types

Discover

AuthorMarsden, (243)De Bono, Johann (135)Eeles, Rosalind (89)Parker, Chris (74)Dearnaley, David (69)... View MoreSubject
Male (1030)
Humans (1013)Female (641)Middle Aged (578)Aged (523)... View MoreDate Issued2020 - 2023 (127)2010 - 2019 (825)2001 - 2009 (28)Publication TypeJournal Article (1023)Other (6)Conference Proceeding (1)
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.